Chris LaCoursiere

@ChrisLaCoursie1

VC consultant Clinical Pharmacist focus oncology patient advocate glioblastoma Seeking Alpha author searching for undervalued equities world over...

Kennebunkport, ME
seekingalpha.com/author/chris-l…
Vrijeme pridruživanja: kolovoz 2019.
50 fotografija ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @ChrisLaCoursie1

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ChrisLaCoursie1

  1. proslijedio/la je Tweet
    prije 20 sati

    cap ~$140billion yet ~$565billion. Efficient markets , yeah tight. ~$9billion , yet $120mio ahead of phase 3 results 😂🙄

    2 proslijeđena tweeta 9 korisnika označava da im se sviđa
    Poništi
  2. proslijedio/la je Tweet
    14. pro 2019.

    There are 8,000 microcaps in North America under $100 million market cap that institutions can’t own until they are larger and more liquid. Find the great ones.

    16 proslijeđenih tweetova 79 korisnika označava da im se sviđa
    Poništi
  3. proslijedio/la je Tweet
    15. pro 2019.

    It shouldn't be surprising that the thing most investors are fearful of... illiquidity... is a powerful driver of returns. Illiquid microcaps have produced 16.05% annual returns while liquid microcaps have produced 0.11% returns. Liquidity dominates size as a return predictor.

    17 replies 104 proslijeđena tweeta 349 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet
    31. sij

    This is what a 10-bagger looks like in the microcap ecosystem Year 1: EPS -0.10 Year 2: EPS 0.10 Year 3: EPS 0.30 You often can’t find them in a screen. You have to dig a little and find them before the earnings power boils to the surface.

    11 replies 52 proslijeđena tweeta 292 korisnika označavaju da im se sviđa
    Poništi
  5. 3. velj

    Jim I forgot to mention is a past BOD for Jon called Weyland a “game changer” as noted in this PR! I hope Dr Jon gets involved again after Weylandtech uplist To in coming weeks

    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  6. 2. velj

    next stock is an unknown they are about to change how do think buying at IPO price prior uplist to trading at 90% discount to fair valuation as noted in PR

    Poništi
  7. proslijedio/la je Tweet
    1. velj
    Odgovor korisnicima

    I’ve worked in cancer care for 20 years. I know oncologists that have read all the science here and believe in this technology (they also are invested). I’ve talked with Dr. Ashkan. The potential for DCVax-L to make a huge change in GBM survival is enormous.

    3 proslijeđena tweeta 15 korisnika označava da im se sviđa
    Poništi
  8. 31. sij

    P3 data will reset valuation 4b in my opinion a conservative estimate upon positive topline data

    1 reply 1 proslijeđeni tweet 16 korisnika označava da im se sviđa
    Poništi
  9. 31. sij

    Most undervalued in my portfolio trading at 90% discount to fair valuation as noted in this press release uplisting to coming weeks will reset intrinsic value 400m market capitalization

    1 korisnik označava da mu se sviđa
    Poništi
  10. proslijedio/la je Tweet
    31. sij

    I lost my uncle to GBM. I've been researching and investing in companies that might make a difference ever since he died. Hopefully this is it.

    all invested in please take a moment to read this post and comment on the site. Every voice matters we are in this for patients, our loved ones, for hope for the future a paradigm change for mankind
    3 proslijeđena tweeta 30 korisnika označava da im se sviđa
    Poništi
  11. proslijedio/la je Tweet
    29. sij

    - Northwest Biotherapeutics: Statistically Significant.

    3 proslijeđena tweeta 25 korisnika označava da im se sviđa
    Poništi
  12. 31. sij

    all invested in please take a moment to read this post and comment on the site. Every voice matters we are in this for patients, our loved ones, for hope for the future a paradigm change for mankind

    1 reply 1 proslijeđeni tweet 16 korisnika označava da im se sviđa
    Poništi
  13. 30. sij

    next stock is

    1 korisnik označava da mu se sviđa
    Poništi
  14. proslijedio/la je Tweet
    30. sij

    More details about Bellicum - MD Anderson manufacturing facility $15M deal

    1 reply 3 proslijeđena tweeta 8 korisnika označava da im se sviđa
    Poništi
  15. proslijedio/la je Tweet
    29. sij

    The most innovative treatments usually get the worst treatment from . Stop protecting big pharma! I love their new guidelines for analyzing trials. The P3 trial appears to be revolutionary for treating GBM, based on interim results!

    great article covers grossly undervalued
    6 proslijeđenih tweetova 19 korisnika označava da im se sviđa
    Poništi
  16. 29. sij

    great article covers grossly undervalued

    2 proslijeđena tweeta 22 korisnika označavaju da im se sviđa
    Poništi
  17. proslijedio/la je Tweet
    28. sij

    Weyland Tech Reports 2019 Preliminary Results: Revenue up 53% to Record $34.6 Million, Driving Fi...

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Poništi
  18. 28. sij

    grossly undervalued

    Poništi
  19. 28. sij

    CARG 40% currently trading at less than 1X revenues of 42m zero debt 10m cash on hand. Projected 2020 revenue of 100m trading at over 10X rev

    1 korisnik označava da mu se sviđa
    Poništi
  20. proslijedio/la je Tweet
    27. sij

    When a company you own puts out great news but the market is down 400 pre market😕😆

    15 replies 22 proslijeđena tweeta 293 korisnika označavaju da im se sviđa
    Poništi

@ChrisLaCoursie1 još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·